🇺🇸 GILD — Gilead Sciences, Inc.

Healthcare Compra
← Volver

Precio actual

151,00 USD

Máx. histórico

157,29

205 días

Caída desde máximo

-4,00%

Rango 52 semanas

108,46 – 157,29

Variación hoy

-0,15%

Cierre anterior

151,22

Rango de hoy

149,23 – 151,19

Volumen hoy

5.977.099

Información
Nombre completo
Gilead Sciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
17.000
PER ⓘ
—
Dividend yield
2,17% (puede no estar actualizado)
Precio objetivo analistas
157,41 USD (puede no estar actualizado)
Primera cotización
22/01/1992
Precio actualizado
hace 1 día
Sobre la empresa

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provides Epclusa, Livdelzi, and Vemlidy to treat chronic hepatitis C virus, primary biliary cholangitis, and chronic hepatitis B virus; Tecartus, a T-cell therapy for the treatment of adult patients; Trodelvy, an injection for intravenous use; and Yescarta, a suspension for intravenous infusion, is a CAR T-cell therapy for the treatment of adult patients. Further, it provides AmBisome, for the treatment of serious invasive fungal infections; and Veklury for the treatment of COVID-19. Additionally, the company engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company has collaboration agreements with Shenzhen Pregene Biopharma Co., Ltd.; Abingworth; Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Dividendos repartidos Total últimos 12 meses: 3,2200 USD · Yield: 2,13%
Fecha de pago Importe por participación
14/09/2022 0,7300 USD
14/06/2022 0,7300 USD
14/03/2022 0,7300 USD
14/12/2021 0,7100 USD
14/09/2021 0,7100 USD
14/06/2021 0,7100 USD
12/03/2021 0,7100 USD
14/12/2020 0,6800 USD
14/09/2020 0,6800 USD
11/06/2020 0,6800 USD
12/03/2020 0,6800 USD
12/12/2019 0,6300 USD
12/09/2019 0,6300 USD
13/06/2019 0,6300 USD
14/03/2019 0,6300 USD
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
12/10/1993 0,50 0,53 0,50 0,52 +2,32% 6,26% 10.931.200
11/10/1993 0,51 0,52 0,50 0,50 -0,77% 3,07% 8.060.800
08/10/1993 0,48 0,52 0,48 0,51 +1,56% 8,05% 5.161.600
07/10/1993 0,49 0,50 0,48 0,50 +1,58% 4,79% 3.548.800
06/10/1993 0,48 0,49 0,46 0,49 +7,70% 7,39% 4.035.200
05/10/1993 0,47 0,48 0,45 0,46 -0,85% 5,01% 854.400
04/10/1993 0,46 0,48 0,45 0,46 +1,72% 5,10% 969.600
01/10/1993 0,45 0,46 0,45 0,45 +0,00% 3,44% 14.438.400
30/09/1993 0,45 0,46 0,45 0,45 +0,00% 3,50% 2.508.800
29/09/1993 0,45 0,45 0,45 0,45 +0,00% 1,72% 1.635.200
28/09/1993 0,45 0,46 0,45 0,45 +0,00% 3,47% 5.980.800
27/09/1993 0,47 0,47 0,45 0,45 +0,00% 5,01% 1.593.600
24/09/1993 0,47 0,47 0,45 0,45 -3,35% 4,18% 3.392.000
23/09/1993 0,45 0,47 0,45 0,47 +3,47% 3,47% 3.456.000
22/09/1993 0,46 0,47 0,45 0,45 -0,85% 3,41% 2.387.200
21/09/1993 0,46 0,46 0,45 0,46 -0,85% 3,38% 11.616.000
20/09/1993 0,45 0,46 0,45 0,46 +3,50% 3,50% 211.200
17/09/1993 0,45 0,47 0,45 0,45 -1,72% 5,19% 2.076.800
16/09/1993 0,47 0,47 0,45 0,45 -3,35% 3,35% 144.000
15/09/1993 0,46 0,47 0,45 0,47 +0,00% 3,41% 1.062.400
14/09/1993 0,48 0,48 0,46 0,47 -3,22% 4,85% 1.056.000
13/09/1993 0,48 0,49 0,48 0,48 +0,00% 1,61% 1.113.600
10/09/1993 0,51 0,52 0,48 0,48 -6,05% 6,14% 3.616.000
09/09/1993 0,52 0,52 0,51 0,52 -0,75% 3,03% 1.395.200
08/09/1993 0,53 0,53 0,52 0,52 +0,76% 2,96% 806.400
07/09/1993 0,53 0,54 0,52 0,52 -4,36% 4,42% 3.904.000
03/09/1993 0,50 0,55 0,48 0,54 +9,53% 12,50% 3.830.400
02/09/1993 0,47 0,50 0,45 0,49 +6,79% 10,00% 3.875.200
01/09/1993 0,46 0,46 0,45 0,46 +0,00% 3,41% 1.696.000
31/08/1993 0,45 0,46 0,45 0,46 +3,50% 3,50% 4.560.000